Last reviewed · How we verify
NCT04126265
Artificial Intelligence-assisted Colonoscopy for Detection of Colon Polyps
NA trial testing Artificial intelligence assisted colonoscopy in Artificial Intelligence in 560 participants. Status unknown.
30 April 2020
Quick facts
| Lead sponsor | Side Liu |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 560 |
| Start date | 1 September 2019 |
| Primary completion | 30 April 2020 |
| Estimated completion | 31 August 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Artificial intelligence assisted colonoscopy
Conditions studied
- Artificial Intelligence — all drugs for Artificial Intelligence →
- Colonoscopy — all drugs for Colonoscopy →
Sponsor
Side Liu
Who can join
Adults 18 to 80, any sex, with Artificial Intelligence or Colonoscopy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All subjects shall sign informed consent before screening, and subjects shall be included according to inclusion and exclusion criteria. A total of four endoscopists were included in the study, two in each group of senior endoscopists and two in each group of junior endoscopists. Patients were randomly enrolled into the senior endoscopy group and the junior endoscopy group, and received artificial intelligence assisted colonoscopy and conventional colonoscopy successively. The two colonoscopy methods were performed back to back by different endoscopy physicians with the same seniority. All patients were examined and treated according to routine medical procedures. The routine colonoscopy group and the artificial-intelligence-assisted colonoscopy group made detailed records of the patients' withdrawal time, entry time, number of polyps detected, polyp Paris classification, polyp size, polyp shape, polyp location and intestinal preparation during the colonoscopy process
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04126265
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Artificial Intelligence
Currently open trials in the same condition.
- NCT07257796 — Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score · recruiting
- NCT07308561 — The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Under · recruiting
- NCT07261618 — AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection · active not recruiting
- NCT07098884 — Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos · recruiting
- NCT06978348 — Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology. · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04126265 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Side Liu
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04126265.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing